EGFR and neoplasm: Among 51 eligible cases, 35 cases undergone systemic anti-tumor therapy included systemic chemotherapy and/or EGFR-TKIs, and 16 cases didn’t have therapy or only have intrapleural injection of cisplatin (Table 1).